<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="65572">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02072538</url>
  </required_header>
  <id_info>
    <org_study_id>UHHD-BM-002</org_study_id>
    <nct_id>NCT02072538</nct_id>
  </id_info>
  <brief_title>Pre-discharge vs. Early Post-discharge Stress Testing and GRACE Score for Safe Discharge of ACS-patients With a Negative Hs-troponin T Result</brief_title>
  <official_title>Role of Pre-discharge vs. Early Post-discharge Stress Testing and Implementation of the GRACE Risk Score for Safe Discharge of Patients With an ACS and a Negative High Sensitivity Troponin T Result Within 3 Hours After Presentation to a Chest Pain Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Heidelberg</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      New high-sensitivity cardiac troponin (hs-cTn) assays allow earlier detection of acute
      myocardial infarction (AMI). Furthermore, elevated values were associated with an increased
      risk of recurrent AMI or death. Therefore, guidelines recommend an early invasive strategy
      in patients with elevated admission values and kinetic changes. Other criteria for an early
      invasive strategy include a GRACE risk score &gt;140 points or other cardiovascular risk
      factors. Hs-cTn assays allow discrimination of patients at very low and high risk. Studies
      confirmed safety of early discharge protocols in patients with unstable angina (UAP). The
      aim of this study is to 1) confirm the safety of early discharge without invasive strategy
      in patients with UAP and to 2) review the optimal timing of stress-testing. Therefore,
      patients are being randomized into 2 groups with pre-discharge and early post-discharge
      stress-testing. Endpoints are major adverse cardiovascular events within 30 and 90 days.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>24 Months</target_duration>
  <primary_outcome>
    <measure>Major adverse cardiovascular event</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiovascular event</measure>
    <time_frame>90 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Major Adverse Cardiovascular Events</condition>
  <condition>Troponin T</condition>
  <condition>GRACE Score</condition>
  <arm_group>
    <arm_group_label>Pre-discharge stress testing</arm_group_label>
    <description>Stress-testing (e.g. treadmill exercise test, stress-echochardiography)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-discharge stress testing</arm_group_label>
    <description>Stress-testing (e.g. treadmill exercise test, stress-echochardiography)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting to our emergency department (&quot;chest pain unit&quot;) with typical angina
        pectoris are being screened for participation. Those meeting the inclusion criteria
        (typical angina pectoris, absence of symptoms since presentation, low GRACE risk score)
        are included.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients presenting to the emergency department (&quot;chest pain unit&quot;)

          -  typical angina pectoris

          -  absence of symptoms since presentation

          -  at least 18 years

          -  low GRACE risk score (&lt;140 points)

          -  informed consent, signed agreement

        Exclusion Criteria:

          -  conditions with need for immediate workup

          -  mental disorders

          -  dementia

          -  pregnancy, breast feeding
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evangelos Giannitsis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hugo A Katus, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evangelos Giannitsis, MD</last_name>
    <email>evangelos_giannitsis@med.uni-heidelberg.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 26, 2014</lastchanged_date>
  <firstreceived_date>February 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Heidelberg</investigator_affiliation>
    <investigator_full_name>Professor Hugo Katus</investigator_full_name>
    <investigator_title>Head of Cardiology</investigator_title>
  </responsible_party>
  <keyword>Stress testing</keyword>
  <keyword>Troponin T</keyword>
  <keyword>GRACE score</keyword>
  <keyword>Outcome</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
